DB289

· Immtech Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DB289, covering 2008-01-29 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) [Phase 3]